<unk>  is a autonomic ganglionic blocker that is FDA approved for the {{{indicationType}}} of moderately severe to severe essential hypertension and uncomplicated cases of malignant hypertension.   Common adverse reactions include orthostatic hypotension, dizziness, lightheadedness, and fainting.
Mecamylamine
Suxamethonium chloride
Oogonium
Neostigmine
Physostigmine
Benzethonium chloride
Neostigmine methylsulfate
Pyridostigmine